Technical Analysis for RDY - Dr. Reddy's Laboratories Ltd

Grade Last Price % Change Price Change
grade B 39.11 2.89% 1.10
RDY closed up 2.89 percent on Friday, September 20, 2019, on 2.44 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical RDY trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Doji - Bearish? Reversal 0.00%
Fell Below 200 DMA Bearish 2.89%
Doji - Bullish? Reversal 2.89%
200 DMA Support Bullish 2.70%
Down 3 Days in a Row Weakness 2.70%
Down 4 Days in a Row Weakness 2.70%
200 DMA Support Bullish 2.36%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.36%

Older signals for RDY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company. It operates in three segments: Pharmaceutical services and Active Ingredients (PSAI), Global Generics, and Proprietary Products. The PSAI segment develops active pharmaceutical ingredients (APIs) and intermediaries, which are used as principal ingredients for finished pharmaceutical products. This segment also offers contract research services to biotech and pharmaceutical companies; and manufactures and sells APIs and steroids in accordance with the specific customer requirements. The Global Generics segment produces and markets finished pharmaceutical products as branded formulations or generic finished dosages. This segment also engages in the operation of biologics business. The Proprietary Products segment engages in the discovery and development of new chemical entities for subsequent commercialization and out-licensing. It offers new, synergistic combination, and technology formulations that modifies pharmacokinetics of existing medicines. This segment is also involved in the Company's specialty pharmaceuticals business that includes sales and marketing operations for in-licensed and co-developed dermatology. The company offers its products and services primarily in the areas of gastrointestinal, cardiovascular, pain management, and oncology therapies. It primarily operates in India, the United States, Russia and other countries of the former Soviet Union, Europe, and others. Dr. Reddy's Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.
Health Pharmaceutical Pharmaceutical Industry Pharmaceuticals Pharmaceutical Products Pharmaceutical Industry In China Pharmaceuticals Policy Pain Management Active Pharmaceutical Ingredients Cnx Nifty Pharmacokinetics Economy Of India Chemical Entities Contract Research Services Dr. Reddy's Laboratories Lupin Limited Oncology Therapies
Is RDY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 42.82
52 Week Low 31.58
Average Volume 196,662
200-Day Moving Average 38.0516
50-Day Moving Average 36.873
20-Day Moving Average 37.2435
10-Day Moving Average 38.576
Average True Range 0.8575
ADX 29.98
+DI 37.8493
-DI 16.8749
Chandelier Exit (Long, 3 ATRs ) 37.2975
Chandelier Exit (Short, 3 ATRs ) 37.2425
Upper Bollinger Band 40.3522
Lower Bollinger Band 34.1348
Percent B (%b) 0.8
BandWidth 16.69392
MACD Line 0.6713
MACD Signal Line 0.5408
MACD Histogram 0.1305
Fundamentals Value
Market Cap 6.48 Billion
Num Shares 166 Million
EPS 1.07
Price-to-Earnings (P/E) Ratio 36.55
Price-to-Sales 2.69
Price-to-Book 3.07
PEG Ratio 0.00
Dividend 0.31
Dividend Yield 0.79%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.41
Resistance 3 (R3) 41.40 40.64 41.02
Resistance 2 (R2) 40.64 40.05 40.64 40.89
Resistance 1 (R1) 39.87 39.69 40.26 39.88 40.77
Pivot Point 39.11 39.11 39.30 39.11 39.11
Support 1 (S1) 38.34 38.52 38.73 38.35 37.45
Support 2 (S2) 37.58 38.16 37.58 37.33
Support 3 (S3) 36.81 37.58 37.20
Support 4 (S4) 36.82